| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.005 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |